Evaluating the Impact of a Technologically-Enhanced Personal Coaching Program on Hemoglobin A1c in Type 2 Diabetics

Evaluation of the Effects of a Technologically-Enhanced Personal Coaching Program on Hemoglobin A1c in Type 2 Diabetics

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03719911

Enrollment

Registered

2018-10-25

Start date

2018-08-05

Completion date

2019-07-01

Last updated

2019-09-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Brief summary

Participants diagnosed with Type 2 diabetes receive personal coaching from a Certified Diabetic Educator (CDE) over a six-month period. The coaching program is enhanced using an mobile application and care management platform.

Detailed description

Participants diagnosed with Type 2 diabetes receive personal coaching from a Certified Diabetic Educator (CDE) over a six-month period. The coaching program is enhanced by integrating a participant-facing mobile application with the coaching platform. Blood glucose test results automatically populate the coaching platform, providing the CDE with information that may better support their coaching efforts. The participants complete Diabetes Self Management Education (DSME) learning modules for the first 7-12 weeks. Following completion of the modules, the coach continues to provide support to the participant until 24 weeks after the participant's enrollment.

Interventions

BEHAVIORALLive diabetes coaching program

Live diabetes coaching program

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Intervention model description

single-arm 24-week pre-post study

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Lives in the United States * Speaks and understands English * Has a Type 2 diabetes mellitus diagnosis * Has a LifeScan Verio Flex blood glucose meter, which is connected to OneTouch Reveal ® app * Has a verified A1c ≥ 8% * Willing to participate in coaching program

Exclusion criteria

* Uses a continuous glucose monitoring device * Currently pregnant * Unable to make lifestyle behavioral changes due to a cognitive or physical disability * Has end stage renal disease (ESRD) diagnosis * Is not able to read or understand English

Design outcomes

Primary

Measure	Time frame	Description
Change in Hemoglobin A1c	A1c measured at baseline, at 12 weeks since study enrollment, and at 24 weeks since enrollment, which marks the participant's completion of the study	Blood serum test to measure glucose control

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026